Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 23428-77-5 | MDL No. : | MFCD00183289 |
Formula : | C16H16O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KENKREVUSRTHDA-UHFFFAOYSA-N |
M.W : | 256.30 g/mol | Pubchem ID : | 307190 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.19 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 74.11 |
TPSA : | 35.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.71 cm/s |
Log Po/w (iLOGP) : | 2.7 |
Log Po/w (XLOGP3) : | 3.04 |
Log Po/w (WLOGP) : | 3.32 |
Log Po/w (MLOGP) : | 2.49 |
Log Po/w (SILICOS-IT) : | 3.81 |
Consensus Log Po/w : | 3.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.48 |
Solubility : | 0.0846 mg/ml ; 0.00033 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.45 |
Solubility : | 0.0905 mg/ml ; 0.000353 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -5.53 |
Solubility : | 0.000762 mg/ml ; 0.00000297 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.1 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With potassium carbonate In acetone at 20℃; for 0.5 h; Stage #2: for 16 h; Reflux |
In 200 ml flask solanaceae of, 3-hydroxy -4 methoxyacetic aminoacetophenone of 4. 66g (28. 1mmol, 1. 0eq. ), Potassium carbonate 3. 89g (28. 1mmol, 1. 0eq. ), Containing 50 ml monohydroxyacetone, 30 minutes after stirring at room temperature, 3 a benzyl bromide. 5 ml (29. 4mmol, 1. 0eq. ) Addition, 16 back to the time. After cooling, condensing, purified water is added to 150 ml, extracted with chloroform (100 ml × 4), magnesium sulfate waterlessly org. layer by drying, filtering, concentrated, recrystallization (ethyl acetate 3 ml), suction filtration, vacuum drying, a first crystal is obtained. Concentrating somas, recrystallization (ethyl acetate 0. 5 ml), suction filtration, vacuum drying, a second crystal is obtained. The corallite crystal (compd. (IV1)), yielding: 6. 69g (26. 1mmol, 93percent)is obtained. |
[ 34068-01-4 ]
1-(3-(Benzyloxy)phenyl)ethanone
Similarity: 0.96
[ 31526-71-3 ]
1-(3-Ethoxy-4-methoxyphenyl)ethanone
Similarity: 0.94
[ 4049-39-2 ]
4-(Benzyloxy)-3-hydroxybenzaldehyde
Similarity: 0.92
[ 34068-01-4 ]
1-(3-(Benzyloxy)phenyl)ethanone
Similarity: 0.96
[ 31526-71-3 ]
1-(3-Ethoxy-4-methoxyphenyl)ethanone
Similarity: 0.94
[ 4049-39-2 ]
4-(Benzyloxy)-3-hydroxybenzaldehyde
Similarity: 0.92
[ 34068-01-4 ]
1-(3-(Benzyloxy)phenyl)ethanone
Similarity: 0.96
[ 31526-71-3 ]
1-(3-Ethoxy-4-methoxyphenyl)ethanone
Similarity: 0.94
[ 2879-20-1 ]
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone
Similarity: 0.94
[ 20632-12-6 ]
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)propan-1-one
Similarity: 0.92